Can this be mixed with aminoglycoside antibiotics?

No, it should be prepared and injected separately because aminopenicillins can inactivate aminoglycoside antibiotics in vitro.

What certifications does the manufacturer hold?

The manufacturer holds GMP, ISO9001, and ISO14001 certifications.

What is the lead time for orders?

The average lead time is 1-3 months for both peak and off-peak seasons.

Ampicillin Sodium and Sulbactam Sodium for Injection with GMP 0.75g/1.5g

Name: Ampicillin Sodium and Sulbactam Sodium for Injection with GMP 0.75g/1.5g
Brand: REYOUNG PHARMACEUTICAL CO., LTD.
SKU: 937872955

Shandong, ChinaREYOUNG PHARMACEUTICAL CO., LTD.

US$42.90-54.80

7,500 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For external use

Model NO.

0.75g/1.5g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Oral Liquid

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H20013187

Indate

3years

Sterile

Color

White

Standard

Bp/Cp

Transport Package

50vials/Tray/Box, 20boxes/Carton

Specification

0.75g/1.5g

Trademark

Reyoung

Origin

China

HS Code

3003101900

Production Capacity

20000000vials/Year

Key features

Broad-Spectrum Indications: Treats respiratory, urinary, peritoneal, skin, bone, joint, and gonococcal infections caused by sensitive bacteria.

Prophylactic Use: Reduces wound infection risk during abdominal/pelvic surgery and lowers post-operative sepsis risk in C-sections.

GMP & ISO Certified: Manufactured under GMP, ISO9001, and ISO14001 standards ensuring quality and safety compliance.

Sterile Formulation: Available as a sterile white powder for injection in 0.75g/1.5g specifications.

Manufacturer Direct: Produced by a major manufacturer with 370 R&D engineers and 1,080,000 sqm plant area.

OEM/ODM Services: Custom branding and manufacturing services available for global partners.

Flexible Payment Terms: Accepts LC, T/T, and D/P payment methods for international trade.

Global Export Capability: Serves markets in South America, Southeast Asia, Middle East, and Africa with 1-3 month lead time.

Company profile

REYOUNG PHARMACEUTICAL CO., LTD.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤18h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.

Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.

CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.

Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.

Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What infections does this product treat?

It treats infections from sensitive bacteria including respiratory tract infections, urinary tract infections, peritonitis, skin and joint infections, and gonococcal infections.

Q:Who can use this medication?

It is suitable for the elderly, children, and adults, but is contraindicated for patients with a history of allergic reactions to penicillin.

Q:What are the available specifications?

The product is available in 0.75g/1.5g specifications as a sterile white powder for injection.

Q:Is this product suitable for pregnant women?

It can be used as a prophylactic during termination of pregnancy or caesarean sections to reduce the risk of post-operative sepsis.

Q:What are the storage conditions?

The product has an in-date of 3 years and must be stored as a sterile solid.